BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
8 | 522.15 | 522.95 | 12 |
19 | 522.10 | 523.00 | 4 |
13 | 522.05 | 523.10 | 8 |
13 | 521.80 | 523.15 | 30 |
54 | 521.75 | 523.20 | 11 |
6610 | Total | Total | 7445 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
8 | 522.15 | 522.95 | 12 |
19 | 522.10 | 523.00 | 4 |
13 | 522.05 | 523.10 | 8 |
13 | 521.80 | 523.15 | 30 |
54 | 521.75 | 523.20 | 11 |
6610 | Total | Total | 7445 |
Stock with medium financial performance with average price momentum and val
Open | 521.00 |
Previous Close | 516.00 |
Volume | 120,388.00 |
Value (Lacs) | 629.33 |
VWAP | 527.19 |
Beta | 0.740.70 |
High | 538.05 |
Low | 521.00 |
UC Limit | 616.80 |
LC Limit | 411.20 |
52 Week High | 631.75 |
52 Week Low | 425.70 |
TTM EPS | 17.83 |
TTM PE | 29.32 |
Sector PE | 32.57 |
Book Value Per Share | 59.99 |
P/B | 8.72 |
Face Value | 1.00 |
Mkt Cap (Rs. Cr.) | 13,307 |
Dividend Yield | 0.96 |
20D Avg Volume | 224,715 |
20D Avg Delivery(%) | 46.27 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Suven Pharma Consolidated March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y May 09 2022 09:05 PM
Suven Pharma Standalone March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y May 09 2022 09:05 PM
Hot Stocks | Double-digit returns in Suven Pharma, EID Parry, Prakash Pipes possible in short term, here's why Apr 27 2022 06:04 AM
Hot Stocks | Double-digit returns from ICICI Prudential, Suven Pharma, Bank of Baroda possible in short term, here's why Mar 30 2022 07:03 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 5000 | Price 640.64 | % Traded 0.00 | Post Tnx Hold. 0.01% |
Qty 2500 | Price 688.15 | % Traded 0.00 | Post Tnx Hold. 0.01% |
Qty 5000 | Price 702.8 | % Traded 0.00 | Post Tnx Hold. 0.01% |
Qty 5000 | Price 685.74 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 10000 | Price 470.31 | % Traded 0.01 | Post Tnx Hold. 0.1% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Suven Pharma | 524.95 | 1.73 | 13,363.39 | 29.44 | 8.75 | 29.71 | -0.33 | 412 | 1,320 | 0.06 |
Sun Pharma | 886.45 | 4.29 | 212,689.05 | 33.21 | 4.30 | 6.24 | 26.12 | 2,284 | 33,498 | 0.07 |
Divis Labs | 4,341.80 | 2.56 | 115,261.15 | 44.89 | 12.40 | 21.34 | 6.90 | 1,984 | 6,969 | 0.00 |
Cipla | 933.70 | 1.41 | 75,332.23 | 29.94 | 3.57 | 12.07 | 3.91 | 2,559 | 21,763 | 0.04 |
Dr Reddys Labs | 3,964.15 | 2.17 | 65,973.70 | 24.96 | 3.74 | 11.06 | -25.23 | 1,903 | 19,047 | 0.17 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>